News

Date	Title (click title to view article)
Mar 9, 2010	New Data Presented at American Burn Association's Annual Meeting Support Safety Profile of RECOTHROM(R) Thrombin, Topical (Recombinant) in Pediatric Patients
Feb 11, 2010	ZymoGenetics Reports Fourth Quarter and Year End 2009 Financial Results
Feb 4, 2010	ZymoGenetics to Host Conference Call and Webcast on February 11, 2010 to Discuss 2009 Year-end Financial Results
Feb 2, 2010	New Publication Supports Safety Profile of RECOTHROM(R) Thrombin, Topical (Recombinant) in Numerous Surgical Settings
Jan 11, 2010	ZymoGenetics Announces Full Exercise of Overallotment Option by Underwriters
Jan 7, 2010	ZymoGenetics Prices Public Offering of Common Stock
Jan 6, 2010	ZymoGenetics Announces Proposed Public Offering of Common Stock
Dec 21, 2009	ZymoGenetics and Bayer Restructure RECOTHROM(R) Agreements
Dec 8, 2009	Novo Nordisk Licenses IL-21 mAb and Patent Rights to IL-21 Antibodies from ZymoGenetics